EP3247464
USE OF TLR AGONIST AND ANTI-CD47 AGENT TO ENHANCE PHAGOCYTOSIS OF CANCER CELLS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.1.2016EP published:
18.9.2019EP application number:
16740762.6
EPO information:
European Patent Register
Max expiry date:
20.1.2036
Title:
USE OF TLR AGONIST AND ANTI-CD47 AGENT TO ENHANCE PHAGOCYTOSIS OF CANCER CELLS
Timeline
Today
21.1.2016EP application
18.9.2019EP Publication
Owner
Name:
The Board of Trustees of the Leland Stanford Junior UniversityAddress:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, 94305-2038, Stanford, CA, US
Inventor
Name:
WEISSMAN, Irving L.Address:
Stanford, California, US
Name:
FENG, MingyeAddress:
Mountain View, California, US
Name:
VOLKMER, Jens-PeterAddress:
Menlo Park, California, US
Priority
Number:
201562106050 PDate:
21.1.2015Country:
US
Classification
Categories:
A61P 35/00, A61K 39/395, A61K 39/00, A61K 31/33, A61K 35/15, A61K 45/06, A61P 7/00, A61K 31/4745, A61K 31/713, A61K 31/519, C12N 5/0786